the present invention provides medicaments useful for reducing phosphorus serum level , especially in those subjects affected from hyperphosphatemia . more specifically , the present invention relates to pharmaceutical compositions to be administered by oral route in fasting periods , in order to absorb phosphorus compounds from fluids of the enteric tract , especially from saliva .